What is the current size of the ophthalmic viscosurgical devices market?

In 2027 the market for ophthalmic viscosurgical devices is worth approximately USD 547.36 million.

How much is the ophthalmic viscosurgical devices industry expected to grow by 2036?

Ophthalmic Viscosurgical Devices Market size was more than USD 521.1 million in 2026 and is set to grow at a 5.99% CAGR between 2027 and 2036, surpassing USD 932.33 million by 2036.

How is the growing geriatric population influencing surgical demand in the ophthalmic viscosurgical devices market?

Increasing age-related eye disorders are driving higher volumes of cataract and glaucoma surgeries. This directly raises utilization of ophthalmic viscosurgical devices to support safer, more controlled intraocular procedures in aging patients.

How is expansion of specialized eye care infrastructure affecting procedural adoption in the ophthalmic viscosurgical devices market?

Growth of dedicated eye care centers is increasing access to minimally invasive surgeries. Standardized high-volume procedures in these facilities are boosting recurring use of ophthalmic viscosurgical devices across routine surgical workflows.

Why is the Biological source segment the largest in the ophthalmic viscosurgical devices market?

Biological accounted for 41.76% of the market in 2026, supported by established clinical familiarity and continued preference for materials with well-understood handling characteristics during ophthalmic procedures.

What is driving the rapid growth of the Viscoadaptive segment in the ophthalmic viscosurgical devices market?

Viscoadaptive is the fastest-growing type because it offers greater intraoperative flexibility, enabling surgeons to maintain better procedural control without switching between multiple materials during surgery.

Why is North America the largest ophthalmic viscosurgical devices market?

North America leads due to high ophthalmic surgery volumes, broad access to specialized eye care, and consistent use of advanced viscosurgical consumables across hospitals and ambulatory surgical centers.

What is driving ophthalmic viscosurgical devices market growth in Asia Pacific?

Asia Pacific is expected to expand at a 7.23% CAGR as ophthalmology services grow, surgical access improves, and providers increase the routine use of modern consumables in eye procedures.

Who are the leading players in the ophthalmic viscosurgical devices landscape?

Leading companies in the ophthalmic viscosurgical devices market include Alcon Inc. (Switzerland), Johnson & Johnson Services, Inc. (United States), Bausch + Lomb Corporation (Canada), Carl Zeiss Meditec AG (Germany), Rayner Group (United Kingdom), Beaver-Visitec International, Inc. (United States), Bohus BioTech AB (Sweden), Nordic Pharma, Inc. (United States), STAAR Surgical Company (United States), HOYA Corporation (Japan).